Literature DB >> 29378709

Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.

Kei-Ichi Uchiya1, Shoki Asahi2, Kazunori Futamura2, Hiromitsu Hamaura3, Taku Nakagawa4,5, Toshiaki Nikai2, Kenji Ogawa4,5.   

Abstract

Mycobacterium avium subsp. hominissuis mainly causes disseminated infection in immunocompromised hosts, such as individuals with human immunodeficiency virus (HIV) infection, and pulmonary infection in immunocompetent hosts. However, many aspects of the different types of M. avium subsp. hominissuis infection remain unclear. We examined the antibiotic susceptibilities and genotypes of M. avium subsp. hominissuis isolates from different hosts by performing drug susceptibility testing using eight antibiotics (clarithromycin, rifampin, ethambutol, streptomycin, kanamycin, amikacin, ethionamide, and levofloxacin) and variable-number tandem-repeat (VNTR) typing analysis for 46 isolates from the sputa of HIV-negative patients with pulmonary M. avium subsp. hominissuis disease without previous antibiotic treatment and 30 isolates from the blood of HIV-positive patients with disseminated M. avium subsp. hominissuis disease. Interestingly, isolates from pulmonary M. avium subsp. hominissuis disease patients were more resistant to seven of the eight drugs, with the exception being rifampin, than isolates from HIV-positive patients. Moreover, VNTR typing analysis showed that the strains examined in this study were roughly classified into three clusters, and the genetic distance from reference strain 104 for isolates from pulmonary M. avium subsp. hominissuis disease patients was statistically significantly different from that for isolates from HIV-positive patients (P = 0.0018), suggesting that M. avium subsp. hominissuis strains that cause pulmonary and disseminated disease have genetically distinct features. Significant differences in susceptibility to seven of the eight drugs, with the exception being ethambutol, were noted among the three clusters. Collectively, these results suggest that an association between the type of M. avium subsp. hominissuis infection, drug susceptibility, and the VNTR genotype and the properties of M. avium subsp. hominissuis strains associated with the development of pulmonary disease are involved in higher levels of antibiotic resistance.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium avium subsp. hominissuis; antibiotic susceptibility; disseminated disease; pulmonary disease; variable-number tandem repeats

Mesh:

Substances:

Year:  2018        PMID: 29378709      PMCID: PMC5913955          DOI: 10.1128/AAC.02035-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

3.  Genetic diversity of Mycobacterium avium subsp. hominissuis strains isolated from humans, pigs, and human living environment.

Authors:  Tomotada Iwamoto; Chie Nakajima; Yukiko Nishiuchi; Tomoko Kato; Shiomi Yoshida; Noriko Nakanishi; Aki Tamaru; Yutaka Tamura; Yasuhiko Suzuki; Masao Nasu
Journal:  Infect Genet Evol       Date:  2011-07-02       Impact factor: 3.342

Review 4.  Pulmonary disease caused by nontuberculous mycobacteria.

Authors:  Curtis H Weiss; Jeffrey Glassroth
Journal:  Expert Rev Respir Med       Date:  2012-12       Impact factor: 3.772

5.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Authors:  David E Griffith; Barbara A Brown-Elliott; Brett Langsjoen; Yansheng Zhang; Xi Pan; William Girard; Kenwyn Nelson; James Caccitolo; Julio Alvarez; Sara Shepherd; Rebecca Wilson; Edward A Graviss; Richard J Wallace
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

6.  The isolation of Mycobacterium avium complex from soil, water, and dusts.

Authors:  S Ichiyama; K Shimokata; M Tsukamura
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

7.  [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].

Authors:  Noriko Kawata; Shin Kawahara; Atsuhiko Tada; Nagio Takigawa; Takuo Shibayama; Ryo Soda; Kiyoshi Takahashi
Journal:  Kekkaku       Date:  2006-04

8.  ASSOCIATION BETWEEN A pMAH135 PLASMID AND THE PROGRESSION OF PULMONARY DISEASE CAUSED BY MYCOBACTERIUM AVIUM.

Authors:  Makoto Moriyama; Kenji Ogawa; Taku Nakagawa; Toshiaki Nikai; Kei-ichi Uchiya
Journal:  Kekkaku       Date:  2016-01

9.  Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year period.

Authors:  Kathleen L Horan; Robert Freeman; Kris Weigel; Makeda Semret; Stacy Pfaller; Terry C Covert; Dick van Soolingen; Sylvia C Leão; Marcel A Behr; Gerard A Cangelosi
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS.

Authors:  C F von Reyn; J N Maslow; T W Barber; J O Falkinham; R D Arbeit
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

View more
  3 in total

1.  Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis.

Authors:  Reaz Uddin; Bushra Siraj; Muhammad Rashid; Ajmal Khan; Sobia Ahsan Halim; Ahmed Al-Harrasi
Journal:  Pathogens       Date:  2020-05-12

2.  Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition.

Authors:  Eric C Keen; JooHee Choi; Meghan A Wallace; Michelle Azar; Carlos R Mejia-Chew; Shail B Mehta; Thomas C Bailey; Lindsay J Caverly; Carey-Ann D Burnham; Gautam Dantas
Journal:  mSystems       Date:  2021-10-19       Impact factor: 6.496

3.  The recombination-cold region as an epidemiological marker of recombinogenic opportunistic pathogen Mycobacterium avium.

Authors:  Hirokazu Yano; Haruo Suzuki; Fumito Maruyama; Tomotada Iwamoto
Journal:  BMC Genomics       Date:  2019-10-17       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.